Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MDxHealth SA - Ordinary Shares (NQ: MDXH )

2.600 -0.200 (-7.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,557
Open 2.700
Bid (Size) 2.590 (40)
Ask (Size) 2.720 (2)
Prev. Close 2.800
Today's Range 2.560 - 2.799
52wk Range 2.150 - 4.640
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q2 2024
MDXH stock results show that MDxHealth missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
MDxHealth Reports Q2 and Half Year 2024 Results
From mdxhealth
Via GlobeNewswire

Performance

YTD
-37.20%
-37.20%
1 Month
-4.06%
-4.06%
3 Month
-10.03%
-10.03%
6 Month
-9.09%
-9.09%
1 Year
-17.20%
-17.20%

More News

Read More
MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21
From mdxhealth
Via GlobeNewswire
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance
From mdxhealth
Via GlobeNewswire
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors
From mdxhealth
Via GlobeNewswire
BTIG Maintains Buy Rating for MDxHealth: Here's What You Need To Know
Via Benzinga
Mdxhealth to Present at Upcoming Investor Conferences
From mdxhealth
Via GlobeNewswire
MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
From mdxhealth
Via GlobeNewswire
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
From mdxhealth
Via GlobeNewswire
These Analysts Increase Their Forecasts On MDxHealth After Q4 Results
Via Benzinga
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
From mdxhealth
Via GlobeNewswire
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6
From mdxhealth
Via GlobeNewswire
TD SYNNEX, Albertsons And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Earnings Scheduled For March 6, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
Via Benzinga
Short Volatility Alert: Mdxhealth
Via Benzinga
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.